MAY 15, 2018 8:10 PM PDT

Cancer Education Resources for Patients

WRITTEN BY: Mauri Brueggeman

Have you ever met patients or people who did not have a medical background? Have you heard them tell you that medicine is so hard to understand and when given a complex diagnosis like cancer, understanding what is happening seems like a whirlwind?  This test and that test…X treatment versus Y treatment…some kind of something therapy…markers mean what exactly…etc.? 

A cancer diagnosis is complex.  Even the term “cancer” has connections to other diagnostic words that can mean cancer but sound very different including neoplasia, malignancy, tumor, neoplasm, and oncogenes.  Educators and those in the medical field know this language but it is still very foreign to so many. 

The National Comprehensive Cancer Network (NCCN®) has developed patient education tools in an effort to provide basic information about individual cancers including etiology (how and where it develops), diagnosis, tests, marker details, treatment planning, treatment options, differing prognostic indicators, supportive care ideas, helpful questions to ask, things to possibly expect, helpful website links, and a list of acronyms near the end of the booklet.  There are diagrams and pictures to help in patients’ understanding.    NCCN® collaborates with other organizations to garner support for their tools and lists those collaborators in these booklets as well.

The provider and oncology staff help patients immensely with their questions and to help navigate the process and experience; however, having tools like this in the hands of patients, developed almost like a learning workbook with spaces for notes and individualization, make these an excellent tool for patients to have on hand when they aren’t with people who can define this test or that. 

The goal of these tools is to help patient’s in the shared decision-making process and to make informed decisions.  Because many of these cancer diagnoses are so complex based on numerous factors, patients don’t even realize one individual’s Acute Myeloid Leukemia (AML) diagnosis can look very different and need different treatment than the next person’s.  Some are published in a variety of languages to meet the needs of diverse patient populations.

These booklets are updated with the oldest version not updated yet being Brain Cancer/Gliomas, published in 2016.  The current list of cancer guides includes booklets (ranging in page number but approximately 50+ pages) on:

Acute Lymphoblastic Leukemia

Acute Myeloid Leukemia

Brain Cancer/Gliomas

Breast Cancer: Stage 0

Breast Cancer: Stage I & II

Breast Cancer: Stage III

Breast Cancer: Stage IV

Chronic Lymphocytic Leukemia

Chronic Myeloid Leukemia

Colon Cancer

Diffuse Large B-Cell Lymphoma

Esophageal Cancer

Follicular Lymphoma

Hodgkin Lymphoma

Kidney Cancer

Lung Cancer

Lung Cancer Screening

Malignant Pleural Mesothelioma

Mantle Cell Lymphoma

Melanoma

Multiple Myeloma

Mycosis Fungoides

Myelodysplastic Syndromes

Myeloproliferative Neoplasms

Non-Hodgkin’s Lymphoma-Peripheral T-Cell Lymphoma

Ovarian Cancer

Pancreatic Cancer

Prostate Cancer

Rectal Cancer

Soft Tissue Carcinoma

Stomach Cancer

Thyroid Cancer

Waldenström’s Macroglobulinemia (Lymphoplasmacytic Lymphoma)

Distress Supportive Care after Cancer Diagnosis

Cancer Induced Nausea & Vomiting

Adolescents and Young Adults with Cancer

Source: National Comprehensive Cancer Network

 

About the Author
  • Mauri S. Brueggeman is a Medical Laboratory Scientist and Educator with a background in Cytogenetics and a Masters in Education from the University of Minnesota. She has worked in the clinical laboratory, taught at the University of Minnesota, and been in post secondary healthcare education administration. She is passionate about advances and leadership in science, medicine, and education.
You May Also Like
APR 14, 2021
Clinical & Molecular DX
AI-Powered Imaging System Can Tell If a Patient Is Cancer-Free
APR 14, 2021
AI-Powered Imaging System Can Tell If a Patient Is Cancer-Free
A patient undergoes chemotherapy and radiation for rectal cancer. How do doctors know whether all the malignant tissue h ...
MAY 06, 2021
Cancer
What accounts for the disparities in mortality rates from kidney cancer?
MAY 06, 2021
What accounts for the disparities in mortality rates from kidney cancer?
New research published in the journal Cancers attempts to address gaps in data regarding mortality risk from advanced-st ...
MAY 13, 2021
Genetics & Genomics
Explore Ways to Enhance Biomarker Discovery Research
MAY 13, 2021
Explore Ways to Enhance Biomarker Discovery Research
Enhance your existing research or discover new methods with a suite of NGS tools and techniques to find and characterize ...
MAY 16, 2021
Cancer
Can you guess which drug is both antiviral and immunotherapeutic?
MAY 16, 2021
Can you guess which drug is both antiviral and immunotherapeutic?
Hepatitis B virus (HBV) is the most common cause of liver cancer in the world, resulting in approximately 880,000 deaths ...
MAY 20, 2021
Cancer
High red meat consumption and low education level associated with early-onset colorectal cancer
MAY 20, 2021
High red meat consumption and low education level associated with early-onset colorectal cancer
Research published recently in JNCI Cancer Spectrum reports that higher red meat and alcohol consumption, as well as low ...
JUN 10, 2021
Cell & Molecular Biology
Does Lithium Prevent Colon Cancer?
JUN 10, 2021
Does Lithium Prevent Colon Cancer?
Researchers found that a drug used in the treatment of mental illness can promote the fitness of healthy gut stem cells, ...
Loading Comments...